development

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist DevelopmentDr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025:  Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.…

9 hours ago
HCLTech and Pearson Partner to Accelerate Skills Development, Advance Careers and Bridge the Global Skills Gap in the AI EraHCLTech and Pearson Partner to Accelerate Skills Development, Advance Careers and Bridge the Global Skills Gap in the AI Era

HCLTech and Pearson Partner to Accelerate Skills Development, Advance Careers and Bridge the Global Skills Gap in the AI Era

LONDON and NOIDA, India, July 29, 2025 /PRNewswire/ -- Pearson (FTSE: PSON.L), the world's lifelong learning company, and HCLTech, a…

17 hours ago
2025 AI Expo Opens in Suzhou, Highlighting Innovation in AI Industry Development2025 AI Expo Opens in Suzhou, Highlighting Innovation in AI Industry Development

2025 AI Expo Opens in Suzhou, Highlighting Innovation in AI Industry Development

SUZHOU, China, July 29, 2025 /PRNewswire/ -- The 7th AI Product & Application Expo ("2025 AI Expo"), organized by the…

18 hours ago

IOC reaffirms commitment to advancing sustainable development through sport at the local level

25 July 2025 - Building on its ongoing efforts to support sustainable development through sport, the International Olympic Committee (IOC) has…

5 days ago
Nadcab Labs’ Insights on Blockchain Development Services Adoption for Transparency & TrustNadcab Labs’ Insights on Blockchain Development Services Adoption for Transparency & Trust

Nadcab Labs’ Insights on Blockchain Development Services Adoption for Transparency & Trust

HYDERABAD, India, July 25, 2025 /PRNewswire/ -- Recent insights from Nadcab Labs, a prominent Blockchain Development Company, reveal a marked increase in…

5 days ago

Xinhua Silk Road: China’s TISCO leads green and low-carbon development in steel industry

BEIJING, July 24, 2025 /PRNewswire/ -- In recent years, Taiyuan Iron and Steel (Group) or TISCO, a subsidiary of China…

7 days ago
Panduit Wins Asia Responsible Enterprise Award 2025 for Empowering Youth through Skills DevelopmentPanduit Wins Asia Responsible Enterprise Award 2025 for Empowering Youth through Skills Development

Panduit Wins Asia Responsible Enterprise Award 2025 for Empowering Youth through Skills Development

SINGAPORE, July 23, 2025 /PRNewswire/ -- Panduit Corp has been awarded the prestigious Asia Responsible Enterprise Award (AREA) 2025 under…

7 days ago
the^delta prize launches 5.25 crore national challenge to power local foodpreneurs and advance India’s women-led development goalsthe^delta prize launches 5.25 crore national challenge to power local foodpreneurs and advance India’s women-led development goals

the^delta prize launches 5.25 crore national challenge to power local foodpreneurs and advance India’s women-led development goals

BENGALURU, India, July 21, 2025 /PRNewswire/ -- the^delta prize has launched the aahaar bazaar challenge, a ₹5.25 crore nationwide incentive…

1 week ago
Dev Technosys Announces Top Ranking Among Leading Mobile App Development CompaniesDev Technosys Announces Top Ranking Among Leading Mobile App Development Companies

Dev Technosys Announces Top Ranking Among Leading Mobile App Development Companies

Dev Technosys ranks among top mobile app development companies, recognized for its innovative solutions and commitment to delivering impactful, scalable…

2 weeks ago
Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AMLAptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC:…

2 weeks ago